Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-1|1|263|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-2|1|366|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-3|1|395|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-4|1|450|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-5|1|456|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-6|1|482|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-7|1|532|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-8|1|554|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-9|1|546|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-10|1|585|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-11|1|597|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-12|1|606|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-13|1|616|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-14|1|631|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-15|1|641|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-16|1|648|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-17|1|651|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-18|1|680|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-19|1|685|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-20|1|693|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-21|1|693|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-22|1|698|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-23|1|714|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-24|1|726|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-25|1|724|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-26|1|727|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-27|1|725|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-28|1|730|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-29|1|738|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-30|1|745|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-31|1|752|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-32|1|756|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-33|1|757|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-34|1|766|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-35|1|791|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-36|1|814|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-37|1|816|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-38|1|842|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-39|1|846|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-40|1|858|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-41|1|864|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-42|1|868|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-43|1|867|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-44|1|869|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-45|1|873|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-46|1|871|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-47|1|870|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-1|n/a,TLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-1-48|1|895|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-1|2|171|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-2|2|196|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-3|2|203|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-4|2|241|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-5|2|294|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-6|2|301|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-7|2|312|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-8|2|378|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-9|2|410|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-10|2|415|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-11|2|417|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-12|2|423|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-13|2|434|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-14|2|436|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-15|2|444|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-16|2|459|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-17|2|483|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-18|2|485|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-19|2|505|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-20|2|519|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-21|2|522|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-22|2|544|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-23|2|547|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-24|2|549|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-25|2|554|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-26|2|561|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-27|2|576|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-28|2|583|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-29|2|589|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-30|2|606|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-31|2|617|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-32|2|624|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-33|2|642|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-34|2|642|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-35|2|649|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-36|2|660|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-37|2|674|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-38|2|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-39|2|712|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-40|2|717|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-41|2|725|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-42|2|732|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-43|2|735|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-44|2|737|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-45|2|747|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-46|2|760|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-47|2|766|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-48|2|777|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-49|2|828|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-2|n/a,TLA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-2-50|2|836|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-1|3|210|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-2|3|223|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-3|3|225|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-4|3|296|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-5|3|310|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-6|3|341|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-7|3|396|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-8|3|403|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-9|3|406|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-10|3|433|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-11|3|442|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-12|3|454|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-13|3|481|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-14|3|489|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-15|3|494|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-16|3|511|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-17|3|512|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-18|3|513|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-19|3|517|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-20|3|541|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-21|3|553|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-22|3|570|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-23|3|573|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-24|3|573|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-25|3|573|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-26|3|580|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-27|3|584|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-28|3|584|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-29|3|592|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-30|3|598|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-31|3|599|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-32|3|601|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-33|3|606|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-34|3|621|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-35|3|626|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-36|3|629|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-37|3|630|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-38|3|635|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-39|3|638|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-40|3|641|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-41|3|644|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-42|3|650|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-43|3|652|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-44|3|658|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-45|3|664|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-46|3|667|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-47|3|667|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-48|3|675|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-49|3|676|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-50|3|676|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-51|3|678|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-52|3|681|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-53|3|688|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-54|3|688|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-55|3|699|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-56|3|702|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-57|3|705|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-58|3|717|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-59|3|719|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-60|3|721|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-61|3|731|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-62|3|739|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-63|3|741|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-64|3|741|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-65|3|746|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-66|3|749|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-67|3|761|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-68|3|762|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-69|3|763|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-70|3|770|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-71|3|777|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-72|3|780|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-73|3|784|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-74|3|786|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-75|3|787|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-76|3|790|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-77|3|792|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-78|3|794|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-79|3|795|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-80|3|795|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-81|3|805|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-82|3|806|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-83|3|811|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-84|3|815|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-85|3|816|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-86|3|819|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-87|3|823|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-88|3|831|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-89|3|832|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-90|3|837|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-91|3|860|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-92|3|864|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-93|3|864|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-94|3|869|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-95|3|889|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-96|3|906|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-3|n/a,TLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|97 (97 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-3-97|3|909|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-1|4|9|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-2|4|107|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-3|4|121|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-4|4|121|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-5|4|128|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-6|4|128|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-7|4|147|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-8|4|150|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-9|4|156|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-10|4|157|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-11|4|157|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-12|4|159|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-13|4|162|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-14|4|162|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-15|4|165|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-16|4|174|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-17|4|184|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-18|4|184|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-19|4|190|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-20|4|196|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-21|4|199|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-22|4|203|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-23|4|207|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-24|4|214|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-25|4|217|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-26|4|217|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-27|4|238|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-28|4|239|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-29|4|240|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-30|4|240|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-31|4|249|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-32|4|254|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-33|4|263|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-34|4|269|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-35|4|280|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-36|4|280|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-37|4|280|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-38|4|287|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-39|4|287|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-40|4|291|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-41|4|296|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-42|4|297|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-43|4|328|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-44|4|333|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-45|4|333|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-46|4|337|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-47|4|338|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-48|4|339|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-49|4|343|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-50|4|344|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-51|4|345|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-52|4|346|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-53|4|346|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-54|4|354|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-55|4|357|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-56|4|361|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-57|4|363|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-58|4|364|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-59|4|367|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-60|4|368|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-61|4|373|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-62|4|375|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-63|4|378|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-64|4|382|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-65|4|387|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-66|4|389|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-67|4|391|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-68|4|392|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-69|4|393|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-70|4|393|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-71|4|394|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-72|4|395|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-73|4|396|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-74|4|400|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-75|4|403|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-76|4|406|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-77|4|407|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-78|4|409|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-79|4|409|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-80|4|413|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-81|4|413|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-82|4|415|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-83|4|419|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-84|4|420|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-85|4|422|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-86|4|429|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-87|4|430|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-88|4|431|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-89|4|436|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-90|4|436|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-91|4|437|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-92|4|437|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-93|4|437|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-94|4|438|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-95|4|442|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-96|4|442|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-97|4|443|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-98|4|451|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-99|4|453|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-100|4|454|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-101|4|455|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-102|4|457|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-103|4|457|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-104|4|457|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-105|4|457|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-106|4|458|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-107|4|458|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-108|4|459|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-109|4|460|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-110|4|465|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-111|4|466|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-112|4|466|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-113|4|469|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-114|4|471|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-115|4|472|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-116|4|476|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-117|4|479|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-118|4|490|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-119|4|491|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-120|4|493|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-121|4|494|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-122|4|497|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-123|4|498|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-124|4|499|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-125|4|500|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-126|4|501|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-127|4|504|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-128|4|506|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-129|4|521|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-130|4|525|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-131|4|533|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-132|4|535|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-133|4|537|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-134|4|542|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-135|4|547|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-136|4|547|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-137|4|550|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-138|4|551|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-139|4|556|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-140|4|561|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-141|4|578|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-142|4|583|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-143|4|596|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-144|4|597|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-145|4|617|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-146|4|628|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-147|4|633|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-148|4|653|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-149|4|661|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-4|n/a,TLB 5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|150 (150 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-4-150|4|663|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-1|5|88|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-2|5|211|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-3|5|302|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-4|5|302|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-5|5|413|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-6|5|448|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-7|5|466|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-8|5|461|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-9|5|474|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-10|5|482|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-11|5|511|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-12|5|529|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-13|5|552|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-14|5|555|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-15|5|587|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-16|5|616|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-17|5|626|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-18|5|629|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-19|5|641|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-20|5|648|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-21|5|646|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-22|5|675|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-23|5|673|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-24|5|654|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-25|5|718|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-26|5|746|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-27|5|758|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-28|5|755|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-29|5|769|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-30|5|763|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-31|5|771|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-32|5|771|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-33|5|797|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-34|5|798|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-35|5|800|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-36|5|811|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-37|5|812|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-38|5|828|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-39|5|841|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-40|5|871|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-41|5|883|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-42|5|896|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-43|5|903|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-44|5|918|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-45|5|925|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-46|5|920|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-47|5|929|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-5|n/a,TKA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-5-48|5|1031|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-1|6|267|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-2|6|267|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-3|6|267|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-4|6|268|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-5|6|281|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-6|6|282|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-7|6|291|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-8|6|303|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-9|6|303|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-10|6|314|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-11|6|316|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-12|6|319|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-13|6|325|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-14|6|325|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-15|6|337|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-16|6|338|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-17|6|338|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-18|6|338|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-19|6|339|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-20|6|341|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-21|6|342|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-22|6|350|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-23|6|351|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-24|6|356|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-25|6|360|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-26|6|371|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-27|6|373|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-28|6|373|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-29|6|375|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-30|6|375|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-31|6|378|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-32|6|378|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-33|6|382|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-34|6|387|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-35|6|394|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-36|6|399|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-37|6|403|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-38|6|416|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-39|6|428|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-40|6|429|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-41|6|451|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-42|6|452|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-43|6|452|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-44|6|463|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-45|6|477|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-46|6|483|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-47|6|486|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-48|6|489|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-6|n/a,TKA 5|1|28|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-6-49|6|491|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-1|7|255|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-2|7|260|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-3|7|264|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-4|7|268|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-5|7|340|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-6|7|404|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-7|7|405|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-8|7|418|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-9|7|433|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-10|7|445|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-11|7|460|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-12|7|478|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-13|7|494|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-14|7|503|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-15|7|510|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-16|7|504|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-17|7|517|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-18|7|518|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-19|7|518|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-20|7|534|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-21|7|533|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-22|7|545|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-23|7|539|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-24|7|549|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-25|7|550|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-26|7|579|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-27|7|575|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-28|7|600|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-29|7|610|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-30|7|614|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-31|7|604|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-32|7|623|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-33|7|626|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-34|7|622|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-35|7|633|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-36|7|634|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-37|7|638|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-38|7|631|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-39|7|632|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-40|7|646|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-41|7|670|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-42|7|663|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-43|7|665|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-44|7|662|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-45|7|675|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-46|7|672|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-47|7|676|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-48|7|696|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-49|7|672|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-50|7|674|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-51|7|684|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-52|7|703|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-53|7|701|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-54|7|711|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-55|7|714|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-56|7|7122|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-57|7|705|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-58|7|713|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-59|7|712|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-60|7|728|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-61|7|727|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-62|7|736|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-63|7|739|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-64|7|731|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-65|7|735|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-66|7|736|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-67|7|741|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-68|7|759|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-69|7|769|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-70|7|769|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-71|7|773|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-72|7|773|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-73|7|776|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-74|7|793|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-75|7|792|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-76|7|786|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-77|7|788|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-78|7|798|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-79|7|802|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-80|7|806|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-81|7|814|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-82|7|813|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-83|7|825|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-84|7|815|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-85|7|821|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-86|7|824|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-87|7|833|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-88|7|828|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-89|7|831|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-90|7|835|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-91|7|835|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-92|7|841|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-93|7|845|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-94|7|841|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-95|7|850|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-96|7|853|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-97|7|869|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-98|7|871|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-99|7|889|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-100|7|898|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-7|n/a,TKB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|101 (101 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-7-101|7|894|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-1|8|237|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-2|8|237|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-3|8|237|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-4|8|237|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-5|8|237|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-6|8|237|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-7|8|237|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-8|8|237|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-9|8|237|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-10|8|237|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-11|8|238|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-12|8|260|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-13|8|260|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-14|8|260|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-15|8|261|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-16|8|262|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-17|8|262|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-18|8|268|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-19|8|269|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-20|8|278|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-21|8|279|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-22|8|281|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-23|8|285|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-24|8|285|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-25|8|286|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-26|8|287|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-27|8|287|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-28|8|290|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-29|8|291|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-30|8|296|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-31|8|297|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-32|8|300|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-33|8|300|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-34|8|301|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-35|8|303|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-36|8|303|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-37|8|303|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-38|8|303|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-39|8|303|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-40|8|303|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-41|8|303|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-42|8|309|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-43|8|310|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-44|8|310|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-45|8|313|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-46|8|314|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-47|8|315|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-48|8|315|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-49|8|315|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-50|8|316|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-51|8|316|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-52|8|317|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-53|8|318|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-54|8|323|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-55|8|324|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-56|8|324|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-57|8|325|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-58|8|327|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-59|8|328|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-60|8|328|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-61|8|328|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-62|8|331|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-63|8|333|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-64|8|333|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-65|8|333|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-66|8|334|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-67|8|335|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-68|8|350|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-69|8|350|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-70|8|350|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-71|8|351|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-72|8|351|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-73|8|357|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-74|8|357|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-75|8|358|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-76|8|359|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-77|8|360|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-78|8|361|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-79|8|361|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-80|8|361|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-81|8|361|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-82|8|367|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-83|8|367|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-84|8|367|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-85|8|370|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-86|8|371|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-87|8|382|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-88|8|385|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-89|8|386|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-90|8|387|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-91|8|391|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-92|8|392|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-93|8|396|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-94|8|401|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-95|8|405|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-96|8|406|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-97|8|420|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-98|8|438|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-99|8|455|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-8|n/a,TKB B5|1|152|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined remainder sacrificed at an age of 590 d|5-5-8-100|8|466|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-1|9|204|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-2|9|232|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-3|9|260|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-4|9|269|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-5|9|332|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-6|9|345|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-7|9|357|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-8|9|360|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-9|9|412|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-10|9|416|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-11|9|422|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-12|9|428|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-13|9|432|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-14|9|433|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-15|9|466|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-16|9|499|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-17|9|502|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-18|9|513|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-19|9|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-20|9|515|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-21|9|524|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-22|9|535|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-23|9|541|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-24|9|551|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-25|9|556|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-26|9|559|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-27|9|569|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-28|9|572|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-29|9|579|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-30|9|584|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-31|9|607|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-32|9|622|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-33|9|635|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-34|9|635|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-35|9|636|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-36|9|644|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-37|9|651|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-38|9|651|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-39|9|654|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-40|9|658|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-41|9|658|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-42|9|663|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-43|9|671|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-44|9|676|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-45|9|684|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-46|9|686|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-47|9|686|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-48|9|689|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-49|9|691|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-50|9|692|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-51|9|692|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-52|9|711|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-53|9|719|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-54|9|731|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-55|9|731|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-56|9|741|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-57|9|746|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-58|9|752|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-59|9|767|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-60|9|767|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-61|9|776|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-62|9|780|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-63|9|780|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-64|9|797|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-65|9|805|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-66|9|808|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-67|9|810|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-68|9|811|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-69|9|818|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-70|9|821|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-71|9|830|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-72|9|831|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-73|9|939|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-74|9|844|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-75|9|851|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-76|9|852|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-77|9|854|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-78|9|854|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-79|9|861|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-80|9|865|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-81|9|967|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-82|9|972|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-83|9|878|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-84|9|889|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-85|9|906|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-86|9|907|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-87|9|916|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-88|9|922|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-89|9|950|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-90|9|970|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-91|9|976|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-92|9|990|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-93|9|991|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-9|n/a,RLA KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-9-94|9|1014|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-1|10|155|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-2|10|202|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-3|10|216|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-4|10|239|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-5|10|240|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-6|10|240|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-7|10|267|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-8|10|275|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-9|10|300|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-10|10|335|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-11|10|337|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-12|10|352|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-13|10|378|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-14|10|379|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-15|10|392|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-16|10|402|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-17|10|406|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-18|10|416|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-19|10|437|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-20|10|437|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-21|10|441|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-22|10|441|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-23|10|468|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-24|10|472|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-25|10|484|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-26|10|492|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-27|10|500|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-28|10|504|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-29|10|505|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-30|10|511|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-31|10|519|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-32|10|519|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-33|10|524|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-34|10|527|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-35|10|532|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-36|10|533|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-37|10|548|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-38|10|552|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-39|10|576|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-40|10|580|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-41|10|595|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-42|10|597|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-43|10|598|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-44|10|602|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-45|10|604|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-46|10|614|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-47|10|605|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-48|10|610|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-49|10|616|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-50|10|618|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-51|10|623|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-52|10|623|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-53|10|626|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-54|10|637|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-55|10|637|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-56|10|639|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-57|10|647|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-58|10|647|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-59|10|653|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-60|10|656|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-61|10|670|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-62|10|672|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-63|10|672|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-64|10|673|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-65|10|677|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-66|10|688|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-67|10|689|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-68|10|689|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-69|10|693|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-70|10|695|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-71|10|361|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-72|10|700|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-73|10|700|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-74|10|701|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-75|10|702|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-76|10|702|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-77|10|706|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-78|10|707|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-79|10|713|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-80|10|722|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-81|10|729|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-82|10|737|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-83|10|745|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-84|10|770|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-85|10|785|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-86|10|790|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-87|10|793|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-88|10|803|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-89|10|867|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-90|10|881|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-91|10|882|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-92|10|888|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-93|10|891|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-10|n/a,RLA 25|1|28|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|94 (94 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|only osteosarcoma determined|5-5-10-94|10|982|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-1|11|366|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-2|11|375|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-3|11|376|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-4|11|379|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-5|11|393|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-6|11|414|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-7|11|432|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-8|11|438|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-9|11|439|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-10|11|446|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-11|11|468|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-12|11|480|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-13|11|512|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-14|11|550|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-15|11|551|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-16|11|558|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-17|11|560|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-18|11|564|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-19|11|567|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-20|11|580|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-21|11|591|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-22|11|594|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-23|11|595|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-24|11|602|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-25|11|604|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-26|11|605|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-27|11|607|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-28|11|614|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-29|11|617|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-30|11|623|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-31|11|630|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-32|11|633|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-33|11|635|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-34|11|636|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-35|11|639|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-36|11|642|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-37|11|647|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-38|11|660|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-39|11|661|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-40|11|668|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-41|11|672|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-42|11|675|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-43|11|675|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-44|11|683|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-45|11|691|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-46|11|692|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-47|11|697|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-48|11|698|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-49|11|706|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-50|11|712|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-51|11|714|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-52|11|714|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-53|11|716|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-54|11|720|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-55|11|726|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-56|11|732|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-57|11|733|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-58|11|734|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-59|11|735|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-60|11|738|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-61|11|740|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-62|11|743|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-63|11|744|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-64|11|745|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-65|11|748|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-66|11|753|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-67|11|753|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-68|11|754|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-69|11|756|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-70|11|765|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-71|11|765|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-72|11|768|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-73|11|775|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-74|11|779|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-75|11|780|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-76|11|782|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-77|11|782|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-78|11|782|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-79|11|783|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-80|11|783|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-81|11|785|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-82|11|785|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-83|11|787|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-84|11|787|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-85|11|790|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-86|11|794|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-87|11|796|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-88|11|797|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-89|11|797|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-90|11|800|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-91|11|802|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-92|11|804|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-93|11|805|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-94|11|807|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-95|11|813|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-96|11|815|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-97|11|815|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-98|11|815|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-99|11|816|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-100|11|821|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-101|11|821|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-102|11|826|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-103|11|827|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-104|11|828|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-105|11|829|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-106|11|830|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-107|11|830|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-108|11|833|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-109|11|838|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-110|11|838|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-111|11|839|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-112|11|841|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-113|11|841|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-114|11|841|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-115|11|841|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-116|11|842|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-117|11|851|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-118|11|856|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-119|11|860|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-120|11|861|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-121|11|861|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-122|11|861|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-123|11|863|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-124|11|865|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-125|11|866|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-126|11|866|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-127|11|867|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-128|11|868|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-129|11|868|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-130|11|870|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-131|11|871|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-132|11|872|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-133|11|874|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-134|11|875|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-135|11|875|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-136|11|876|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-137|11|876|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-138|11|877|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-139|11|877|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-140|11|878|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-141|11|881|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-142|11|883|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-143|11|891|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-144|11|892|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-145|11|894|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-146|11|896|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-147|11|896|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-148|11|897|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-149|11|897|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-150|11|897|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-151|11|902|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-152|11|904|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-153|11|906|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-154|11|907|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-155|11|907|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-156|11|907|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-157|11|907|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-158|11|908|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-159|11|908|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-160|11|909|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-161|11|910|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-162|11|910|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-163|11|910|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-164|11|910|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-165|11|911|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-166|11|916|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-167|11|918|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-168|11|924|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-169|11|924|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-170|11|924|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-171|11|925|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-172|11|926|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-173|11|927|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-174|11|929|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-175|11|930|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-176|11|931|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-177|11|932|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-178|11|935|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-179|11|939|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-180|11|940|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-181|11|940|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-182|11|941|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-183|11|941|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-184|11|941|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-185|11|941|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-186|11|943|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-187|11|943|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-188|11|945|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-189|11|946|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-190|11|949|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-191|11|950|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-192|11|955|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-193|11|960|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-194|11|962|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-195|11|962|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-196|11|965|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-197|11|966|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-198|11|968|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-199|11|969|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-200|11|977|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-201|11|977|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-202|11|979|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-203|11|979|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-204|11|981|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-205|11|985|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-206|11|986|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-207|11|987|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-208|11|994|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-209|11|995|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-210|11|996|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-211|11|1001|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-212|11|1002|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-213|11|1003|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-214|11|1005|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-215|11|1006|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-216|11|1007|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-217|11|1014|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-218|11|1017|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-219|11|1024|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-220|11|1025|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-221|11|1025|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-222|11|1032|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-223|11|1038|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-224|11|1039|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-225|11|1041|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-226|11|1047|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-227|11|1052|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-228|11|1055|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-229|11|1057|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-230|11|1064|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-231|11|1074|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-232|11|1092|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-233|11|1101|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-234|11|1104|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-235|11|1113|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-236|11|1127|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-237|11|1163|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-238|11|1169|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-11|n/a,RLB KO|1|152|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|239 (239 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-11-239|11|1206|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-1|12|193|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-2|12|211|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-3|12|260|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-4|12|260|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-5|12|285|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-6|12|298|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-7|12|309|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-8|12|326|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-9|12|326|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-10|12|329|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-11|12|344|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-12|12|348|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-13|12|362|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-14|12|363|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-15|12|392|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-16|12|393|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-17|12|408|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-18|12|411|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-19|12|412|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-20|12|413|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-21|12|415|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-22|12|417|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-23|12|420|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-24|12|420|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-25|12|426|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-26|12|429|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-27|12|430|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-28|12|446|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-29|12|461|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-30|12|461|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-31|12|464|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-32|12|466|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-33|12|467|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-34|12|468|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-35|12|468|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-36|12|477|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-37|12|477|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-38|12|477|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-39|12|482|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-40|12|483|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-41|12|484|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-42|12|495|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-43|12|495|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-44|12|498|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-45|12|502|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-46|12|503|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-47|12|504|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-48|12|505|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-49|12|505|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-50|12|508|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-51|12|508|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-52|12|511|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-53|12|517|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-54|12|517|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-55|12|523|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-56|12|524|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-57|12|529|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-58|12|530|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-59|12|532|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-60|12|533|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-61|12|533|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-62|12|537|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-63|12|537|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-64|12|545|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-65|12|545|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-66|12|546|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-67|12|551|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-68|12|551|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-69|12|552|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-70|12|553|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-71|12|553|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-72|12|554|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-73|12|558|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-74|12|558|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-75|12|558|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-76|12|558|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-77|12|559|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-78|12|559|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-79|12|560|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-80|12|560|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-81|12|565|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-82|12|565|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-83|12|565|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-84|12|566|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-85|12|567|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-86|12|569|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-87|12|574|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-88|12|575|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-89|12|578|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-90|12|579|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-91|12|579|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-92|12|579|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-93|12|581|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-94|12|581|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-95|12|581|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-96|12|587|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-97|12|587|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-98|12|588|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-99|12|588|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-100|12|588|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-101|12|589|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-102|12|589|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-103|12|592|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-104|12|594|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-105|12|596|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-106|12|601|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-107|12|602|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-108|12|603|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-109|12|606|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-110|12|607|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-111|12|608|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-112|12|610|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-113|12|613|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-114|12|613|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-115|12|616|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-116|12|617|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-117|12|617|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-118|12|617|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-119|12|621|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-120|12|621|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-121|12|622|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-122|12|622|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-123|12|623|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-124|12|623|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-125|12|624|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-126|12|626|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-127|12|627|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-128|12|628|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-129|12|628|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-130|12|629|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-131|12|629|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-132|12|642|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-133|12|634|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-134|12|638|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-135|12|644|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-136|12|648|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-137|12|649|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-138|12|650|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-139|12|651|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-140|12|652|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-141|12|653|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-142|12|657|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-143|12|659|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-144|12|661|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-145|12|662|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-146|12|663|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-147|12|665|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-148|12|665|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-149|12|665|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-150|12|671|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-151|12|671|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-152|12|671|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-153|12|676|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-154|12|677|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-155|12|677|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-156|12|678|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-157|12|678|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-158|12|679|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-159|12|680|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-160|12|680|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-161|12|685|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-162|12|686|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-163|12|687|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-164|12|690|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-165|12|693|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-166|12|698|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-167|12|698|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-168|12|698|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-169|12|699|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-170|12|700|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-171|12|700|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-172|12|704|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-173|12|704|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-174|12|704|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-175|12|704|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-176|12|705|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-177|12|706|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-178|12|707|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-179|12|707|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-180|12|711|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-181|12|711|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-182|12|714|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-183|12|715|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-184|12|715|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-185|12|720|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-186|12|720|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-187|12|720|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-188|12|721|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-189|12|725|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-190|12|726|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-191|12|729|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-192|12|736|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-193|12|739|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-194|12|741|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-195|12|741|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-196|12|742|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-197|12|742|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-198|12|743|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-199|12|746|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-200|12|746|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-201|12|746|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-202|12|747|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-203|12|747|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-204|12|750|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-205|12|750|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-206|12|753|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-207|12|753|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-208|12|755|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-209|12|756|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-210|12|762|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-211|12|763|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-212|12|768|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-213|12|771|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-214|12|774|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-215|12|783|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-216|12|784|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-217|12|784|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-218|12|787|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-219|12|788|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-220|12|789|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-221|12|789|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-222|12|794|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-223|12|796|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-224|12|796|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-225|12|801|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-226|12|817|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-227|12|824|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-228|12|848|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-229|12|853|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-230|12|859|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-231|12|862|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-232|12|875|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-233|12|881|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-234|12|899|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-235|12|908|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-12|n/a,RLB 25|1|152|Ra-224 chloride|925|becquerels per g animal|Injection, intraperitoneal|single injection|236 (236 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|only osteosarcoma determined|5-5-12-236|12|910|Other deterministic changes|Bone among musculo-skeletal system diseases|n/a|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-1|13|298|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-2|13|316|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-3|13|379|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-4|13|441|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-5|13|449|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-6|13|494|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-7|13|496|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-8|13|562|Other deterministic changes|Whole body|n/a|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-9|13|562|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-10|13|569|Other deterministic changes|Whole body|n/a|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-11|13|571|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-12|13|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-13|13|586|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-14|13|590|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-15|13|606|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-16|13|611|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-17|13|611|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-18|13|624|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-19|13|646|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-20|13|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-21|13|654|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-22|13|657|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-23|13|657|Other deterministic changes|Whole body|n/a|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-24|13|670|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-25|13|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-26|13|686|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-27|13|704|Other deterministic changes|Whole body|n/a|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-28|13|713|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-29|13|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-30|13|734|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-31|13|744|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-32|13|758|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-33|13|758|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-34|13|765|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-35|13|771|Other deterministic changes|Whole body|n/a|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-36|13|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-37|13|772|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-38|13|776|Other deterministic changes|Whole body|n/a|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-39|13|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-40|13|792|Other deterministic changes|Whole body|n/a|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-41|13|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-42|13|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-43|13|841|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-44|13|842|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-45|13|847|Other deterministic changes|Whole body|n/a|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-46|13|905|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-47|13|911|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-48|13|936|Other deterministic changes|Whole body|n/a|
5-5-13|n/a,TL 12 J|1|30|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (49 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-13-49|13|1023|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-1|14|6|Other deterministic changes|Whole body|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-2|14|341|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-3|14|344|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-4|14|390|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-5|14|420|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-6|14|530|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-7|14|533|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-8|14|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-9|14|557|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-10|14|590|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-11|14|597|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-12|14|600|Other deterministic changes|Whole body|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-13|14|608|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-14|14|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-15|14|637|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-16|14|670|Other deterministic changes|Whole body|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-17|14|677|Other deterministic changes|Whole body|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-18|14|679|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-19|14|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-20|14|683|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-21|14|684|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-22|14|693|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-23|14|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-24|14|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-25|14|716|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-26|14|719|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-27|14|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-28|14|721|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-29|14|726|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-30|14|729|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-31|14|730|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-32|14|733|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-33|14|737|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-34|14|741|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-35|14|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-36|14|750|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-37|14|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-38|14|763|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-39|14|770|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-40|14|800|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-41|14|821|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-42|14|826|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-43|14|828|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-44|14|834|Other deterministic changes|Whole body|n/a|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-45|14|838|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-46|14|842|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-47|14|877|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-48|14|877|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-49|14|968|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-14|n/a,TL 12J1|1|30|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-14-50|14|1023|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-1|15|188|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-2|15|222|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-3|15|265|Other deterministic changes|Whole body|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-4|15|275|Other deterministic changes|Whole body|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-5|15|334|Other deterministic changes|Whole body|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-6|15|391|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-7|15|426|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-8|15|429|Other deterministic changes|Whole body|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-9|15|446|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-10|15|446|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-11|15|446|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-12|15|447|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-13|15|449|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-14|15|468|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-15|15|475|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-16|15|489|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-17|15|496|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-18|15|498|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-19|15|505|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-20|15|520|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-21|15|532|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-22|15|533|Other deterministic changes|Whole body|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-23|15|553|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-24|15|562|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-25|15|566|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-26|15|569|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-27|15|569|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-28|15|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-29|15|583|Other deterministic changes|Whole body|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-30|15|583|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-31|15|587|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-32|15|621|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-33|15|622|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-34|15|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-35|15|649|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-36|15|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-37|15|650|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001487 - mandible|,MPATH: 572 - ossifying fibroma|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-38|15|652|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-39|15|660|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-40|15|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-41|15|677|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-42|15|680|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-43|15|687|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-44|15|702|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-45|15|713|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-46|15|742|Other deterministic changes|Whole body|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-47|15|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-48|15|856|Other deterministic changes|Whole body|n/a|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-49|15|861|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-15|n/a,TL 12 J5|1|30|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-15-50|15|863|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-1|16|30|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-2|16|112|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-3|16|141|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-4|16|180|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-5|16|181|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-6|16|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-7|16|188|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-8|16|210|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-9|16|219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-10|16|226|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-11|16|233|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-12|16|238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-13|16|238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-14|16|242|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-15|16|263|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-16|16|266|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-17|16|281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-18|16|282|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-19|16|289|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-20|16|294|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-21|16|315|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-22|16|334|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-23|16|390|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-24|16|390|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-25|16|392|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-26|16|398|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-27|16|401|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-28|16|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-29|16|407|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-30|16|415|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-31|16|420|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-32|16|421|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-33|16|421|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-34|16|432|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-35|16|439|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-36|16|441|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-37|16|442|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-38|16|448|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-39|16|454|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-40|16|457|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-41|16|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-42|16|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-43|16|470|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-44|16|474|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-45|16|498|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-46|16|505|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-47|16|510|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-48|16|526|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-49|16|553|Other deterministic changes|Whole body|n/a|
5-5-16|n/a,TL 12 A|1|365|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-16-50|16|637|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-1|17|35|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-2|17|96|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-3|17|104|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-4|17|104|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-5|17|108|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-6|17|108|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-7|17|108|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-8|17|117|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-9|17|135|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-10|17|141|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.-lymphatic leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-11|17|145|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-12|17|154|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-13|17|162|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-14|17|170|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-15|17|175|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-16|17|180|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-17|17|180|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-18|17|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-19|17|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-20|17|198|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-21|17|201|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-22|17|202|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-23|17|202|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-24|17|203|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-25|17|203|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-26|17|216|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-27|17|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-28|17|226|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-29|17|237|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-30|17|239|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-31|17|246|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-32|17|247|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-33|17|254|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-34|17|256|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-35|17|264|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-36|17|265|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-37|17|271|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-38|17|274|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-39|17|275|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-40|17|279|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-41|17|281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-42|17|281|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-43|17|281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-44|17|282|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-45|17|282|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-46|17|285|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-47|17|286|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-48|17|287|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-49|17|288|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-50|17|293|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-51|17|301|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-52|17|313|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-53|17|315|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-54|17|316|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-55|17|317|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-56|17|321|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-57|17|327|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-58|17|327|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-59|17|329|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-60|17|330|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-61|17|330|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-62|17|331|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-63|17|334|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-64|17|336|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-65|17|336|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-66|17|338|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-67|17|341|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-68|17|355|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-69|17|361|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-70|17|364|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-71|17|369|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-72|17|367|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-73|17|370|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-74|17|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-75|17|371|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-76|17|373|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-77|17|384|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-78|17|385|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-79|17|386|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-80|17|392|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-81|17|392|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-82|17|397|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-83|17|397|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-84|17|401|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-85|17|408|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-86|17|408|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-87|17|408|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-88|17|411|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-89|17|414|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-90|17|414|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-91|17|415|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-92|17|418|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-93|17|418|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-94|17|418|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-95|17|419|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-96|17|421|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-97|17|427|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-98|17|428|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-99|17|429|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-100|17|435|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-101|17|438|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-102|17|446|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-103|17|446|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-104|17|449|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-105|17|452|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-106|17|460|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-107|17|460|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-108|17|463|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-109|17|471|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-110|17|475|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-111|17|492|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-112|17|495|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-113|17|496|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-114|17|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-115|17|499|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-116|17|499|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-117|17|510|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-118|17|516|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-119|17|531|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-120|17|541|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-121|17|553|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-122|17|587|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-123|17|597|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-124|17|629|Other deterministic changes|Whole body|n/a|
5-5-17|n/a,TL 12 A1|1|365|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|125 (125 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-17-125|17|678|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-1|18|33|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-2|18|55|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-3|18|84|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-4|18|97|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-5|18|112|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-6|18|120|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-7|18|131|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-8|18|131|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-9|18|159|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-10|18|160|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-11|18|169|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-12|18|181|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-13|18|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-14|18|200|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-15|18|201|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-16|18|202|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-17|18|202|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-18|18|211|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-19|18|221|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-20|18|222|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-21|18|231|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-22|18|237|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-23|18|238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-24|18|243|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-25|18|243|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-26|18|246|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-27|18|247|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-28|18|252|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-29|18|260|Neoplasia systemic|Haematolymphatic system|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-30|18|261|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-31|18|261|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-32|18|266|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-33|18|270|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-34|18|272|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-35|18|275|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-36|18|285|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-37|18|308|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-38|18|309|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-39|18|324|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-40|18|338|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-41|18|338|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-42|18|338|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-43|18|344|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-44|18|345|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-45|18|347|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-46|18|352|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-47|18|362|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-48|18|364|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-49|18|373|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-50|18|375|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-51|18|376|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-52|18|384|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-53|18|387|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-54|18|392|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-55|18|392|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-56|18|393|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-57|18|396|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-58|18|397|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-59|18|397|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-60|18|422|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-61|18|422|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-62|18|425|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-63|18|425|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-64|18|426|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-65|18|427|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-66|18|427|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-67|18|428|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-68|18|428|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-69|18|433|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-70|18|443|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-71|18|448|Other deterministic changes|Whole body|n/a|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-72|18|456|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-73|18|478|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-74|18|494|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-18|n/a,TL 12 A5|1|365|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|75 (75 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-5-18-75|18|532|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-1|19|297|Other deterministic changes|Whole body|n/a|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-2|19|317|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-3|19|384|Other deterministic changes|Whole body|n/a|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-4|19|401|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-5|19|435|Other deterministic changes|Whole body|n/a|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-6|19|456|Other deterministic changes|Whole body|n/a|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-7|19|458|Other deterministic changes|Whole body|n/a|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-8|19|465|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-9|19|474|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-10|19|528|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-11|19|549|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-12|19|549|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-13|19|588|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-14|19|588|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-15|19|589|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-16|19|590|Other deterministic changes|Whole body|n/a|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-17|19|605|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-18|19|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-19|19|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-20|19|637|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-21|19|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-22|19|650|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-23|19|665|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-24|19|666|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-25|19|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-26|19|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-27|19|733|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-28|19|738|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-29|19|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-30|19|756|Other deterministic changes|Whole body|n/a|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-31|19|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-32|19|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-33|19|787|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-34|19|790|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-35|19|801|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-36|19|821|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-37|19|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-38|19|826|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-39|19|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-40|19|829|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-41|19|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-42|19|836|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-43|19|839|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-44|19|844|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-45|19|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-46|19|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-47|19|924|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-48|19|944|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-49|19|987|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-19|n/a,TRA KO|1|25|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|49 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-19-50|19|988|Other deterministic changes|Whole body|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-1|20|159|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-2|20|197|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-3|20|216|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-4|20|224|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-5|20|226|Other deterministic changes|Whole body|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-6|20|250|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-7|20|293|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-8|20|302|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-9|20|302|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-10|20|306|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-11|20|317|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-12|20|317|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-13|20|333|Other deterministic changes|Whole body|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-14|20|335|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-15|20|341|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-16|20|341|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-17|20|341|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-18|20|345|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-19|20|356|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-20|20|357|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-21|20|359|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-22|20|363|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-23|20|377|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-24|20|381|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-25|20|395|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-26|20|398|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-27|20|399|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-28|20|407|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-29|20|414|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-30|20|419|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-31|20|429|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-32|20|437|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-33|20|448|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-34|20|475|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-35|20|483|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-36|20|485|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-37|20|488|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-38|20|488|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-39|20|517|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-40|20|523|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-41|20|526|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-42|20|532|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-43|20|554|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-44|20|555|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-45|20|580|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-46|20|581|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-47|20|594|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-48|20|663|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-49|20|720|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-20|n/a,TRA 6|1|25|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Infant|full pathology|5-5-20-50|20|744|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-1|21|13|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-2|21|65|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-3|21|68|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-4|21|76|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-5|21|84|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-6|21|85|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-7|21|96|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-8|21|105|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-9|21|106|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-10|21|108|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-11|21|115|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-12|21|122|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-13|21|122|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-14|21|125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-15|21|136|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-16|21|153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-17|21|163|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-18|21|163|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-19|21|164|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-20|21|167|Other deterministic changes|Whole body|n/a|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-21|21|181|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-22|21|182|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-23|21|183|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-24|21|187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-25|21|191|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-26|21|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-27|21|199|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-28|21|215|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-29|21|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-30|21|223|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-31|21|228|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-32|21|243|Other deterministic changes|Whole body|n/a|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-33|21|246|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-34|21|248|Other deterministic changes|Whole body|n/a|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-35|21|248|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-36|21|248|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-37|21|251|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-38|21|262|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-39|21|272|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-40|21|275|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-41|21|283|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-42|21|328|Other deterministic changes|Whole body|n/a|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-43|21|330|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-44|21|337|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-45|21|344|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-46|21|388|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-47|21|404|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-48|21|422|Other deterministic changes|Whole body|n/a|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-49|21|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-21|n/a,TRB KO|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-21-50|21|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-1|22|16|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-2|22|16|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-3|22|33|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-4|22|43|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-5|22|47|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-6|22|51|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-7|22|57|Other deterministic changes|Whole body|n/a|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-8|22|58|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-9|22|61|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-10|22|61|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-11|22|72|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-12|22|72|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-13|22|72|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-14|22|73|Other deterministic changes|Whole body|n/a|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-15|22|94|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-16|22|101|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-17|22|104|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-18|22|106|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-19|22|125|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-20|22|129|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-21|22|133|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-22|22|141|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-23|22|142|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-24|22|149|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-25|22|152|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-26|22|156|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-27|22|156|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-28|22|160|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-29|22|161|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-30|22|171|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-31|22|171|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-32|22|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-33|22|185|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-34|22|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-35|22|217|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-36|22|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-37|22|228|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-38|22|230|Other deterministic changes|Whole body|n/a|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-39|22|230|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-40|22|233|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-41|22|241|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-42|22|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-43|22|262|Other deterministic changes|Whole body|n/a|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-44|22|262|Other deterministic changes|Whole body|n/a|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-45|22|268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-46|22|274|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-47|22|282|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-48|22|283|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-49|22|287|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001487 - mandible|,MPATH: 572 - ossifying fibroma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-50|22|297|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-51|22|300|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001487 - mandible|,MPATH: 572 - ossifying fibroma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-52|22|301|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-53|22|324|Other deterministic changes|Whole body|n/a|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-54|22|324|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-55|22|349|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-56|22|370|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-57|22|380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-58|22|401|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-22|n/a,TRB 6|1|550|Th-227 citrate|222|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 2 w|59 (59 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-22-59|22|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-1|23|121|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-2|23|162|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-3|23|231|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-4|23|246|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-5|23|292|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-6|23|370|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-7|23|376|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-8|23|385|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-9|23|391|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-10|23|397|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-11|23|398|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-12|23|408|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-13|23|411|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-14|23|419|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-15|23|432|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-16|23|433|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-17|23|433|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-18|23|436|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-19|23|439|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-20|23|439|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-21|23|454|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-22|23|478|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-23|23|482|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-24|23|483|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-25|23|484|Other deterministic changes|Whole body|n/a|
5-5-23|n/a,RT KO|1|28|none (controls)|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|26 (26 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-23-26|23|485|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-1|24|138|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-2|24|148|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-3|24|148|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-4|24|173|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-5|24|212|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-6|24|215|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-7|24|275|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-8|24|285|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-9|24|313|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-10|24|357|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-11|24|358|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-12|24|372|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-13|24|385|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-14|24|386|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-15|24|391|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-16|24|412|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-17|24|412|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-18|24|422|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-19|24|447|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-20|24|456|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-21|24|457|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-22|24|478|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-23|24|488|Other deterministic changes|Whole body|n/a|
5-5-24|n/a,RT KOi|1|28|shamexposed|0|unit code not relevant|not applicable or not supplied|protein diet 13 or 23%|24 (24 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-24-24|24|495|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-1|25|90|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-2|25|189|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-3|25|230|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-4|25|239|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-5|25|240|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-6|25|252|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-7|25|257|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-8|25|303|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-9|25|313|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-10|25|313|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-11|25|336|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-12|25|336|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-13|25|336|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-14|25|338|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-15|25|341|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-16|25|342|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-17|25|352|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-18|25|352|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-19|25|359|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-20|25|363|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-21|25|369|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-22|25|370|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-23|25|372|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-24|25|379|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-25|25|380|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-26|25|383|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-27|25|386|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-28|25|404|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-29|25|404|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-30|25|404|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-31|25|404|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-32|25|406|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-33|25|420|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-34|25|420|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-35|25|421|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-36|25|422|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-37|25|426|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-38|25|428|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-39|25|434|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-40|25|435|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-41|25|439|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-42|25|440|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-43|25|441|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-44|25|443|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-45|25|446|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-46|25|449|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-47|25|457|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-48|25|460|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-49|25|461|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-50|25|474|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-51|25|478|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-52|25|481|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-53|25|482|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-54|25|488|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-55|25|492|Other deterministic changes|Whole body|n/a|
5-5-25|n/a,RT T1|1|28|Th-227 citrate|1|becquerels per g animal|Injection, intraperitoneal|protein diet 13 or 23%|56 (56 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|all bone tumors at daily intervals checked, not in book|5-5-25-56|25|496|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-1|26|272|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-2|26|284|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-3|26|287|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-4|26|379|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-5|26|400|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-6|26|486|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-7|26|488|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-8|26|517|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-9|26|550|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-10|26|574|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-11|26|592|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-12|26|593|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-13|26|634|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-14|26|635|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-15|26|635|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-16|26|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-17|26|649|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-18|26|676|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-19|26|691|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-20|26|698|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-21|26|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-22|26|704|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-23|26|728|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-24|26|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-25|26|741|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-26|26|743|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-27|26|746|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-28|26|746|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-29|26|747|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-30|26|769|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-31|26|774|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-32|26|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-33|26|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-34|26|775|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-35|26|777|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-36|26|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-37|26|797|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-38|26|825|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-39|26|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-40|26|826|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-41|26|838|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-42|26|872|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-43|26|874|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-44|26|893|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-45|26|903|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-46|26|903|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-47|26|938|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-48|26|938|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-49|26|943|Other deterministic changes|Whole body|n/a|
5-5-26|n/a,TRD J|1|31|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-26-50|26|943|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-1|27|153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-2|27|230|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-3|27|298|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-4|27|312|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-5|27|362|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-6|27|420|Other deterministic changes|Whole body|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-7|27|421|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-8|27|427|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-9|27|438|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-10|27|475|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-11|27|481|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-12|27|501|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-13|27|505|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-14|27|524|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-15|27|558|Other deterministic changes|Whole body|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-16|27|592|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-17|27|606|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-18|27|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-19|27|623|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-20|27|638|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-21|27|643|Other deterministic changes|Whole body|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-22|27|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-23|27|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-24|27|669|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-25|27|680|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-26|27|683|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-27|27|684|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-28|27|685|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-29|27|693|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-30|27|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-31|27|711|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-32|27|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-33|27|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-34|27|732|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-35|27|742|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-36|27|760|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-37|27|762|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-38|27|771|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-39|27|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-40|27|776|Other deterministic changes|Whole body|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-41|27|790|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-42|27|832|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-43|27|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-44|27|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-45|27|851|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-46|27|896|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-47|27|957|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-27|n/a,TRD J1|1|31|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-27-48|27|966|Other deterministic changes|Whole body|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-1|28|50|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-2|28|160|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-3|28|190|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-4|28|194|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-5|28|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-6|28|348|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-7|28|351|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-8|28|362|Other deterministic changes|Whole body|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-9|28|363|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-10|28|364|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-11|28|371|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-12|28|386|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-13|28|395|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-14|28|396|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-15|28|410|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-16|28|448|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-17|28|456|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-18|28|474|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-19|28|488|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-20|28|509|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-21|28|522|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-22|28|524|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-23|28|540|Other deterministic changes|Whole body|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-24|28|538|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-25|28|546|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-26|28|558|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-27|28|567|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-28|28|574|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-29|28|586|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-30|28|588|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-31|28|592|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-32|28|593|Other deterministic changes|Whole body|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-33|28|606|Other deterministic changes|Whole body|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-34|28|622|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-35|28|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-36|28|634|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-37|28|634|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-38|28|634|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-39|28|641|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-40|28|644|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-41|28|658|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-42|28|659|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-43|28|690|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-44|28|750|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-45|28|769|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-46|28|770|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-47|28|774|Other deterministic changes|Whole body|n/a|
5-5-28|n/a,TRD J5|1|31|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|48 (48 in ERA)|Mouse|Mouse, NMRI|Female|Juvenile|full pathology|5-5-28-48|28|831|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-1|29|4|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-2|29|6|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-3|29|54|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-4|29|54|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-5|29|57|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-6|29|57|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-7|29|68|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-8|29|68|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-9|29|71|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-10|29|80|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-11|29|92|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-12|29|106|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-13|29|120|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-14|29|127|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-15|29|138|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-16|29|139|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-17|29|146|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-18|29|154|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-19|29|157|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-20|29|159|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-21|29|161|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-22|29|161|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-23|29|169|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-24|29|174|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-25|29|174|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-26|29|185|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-27|29|194|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-28|29|207|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-29|29|211|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-30|29|214|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-31|29|215|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-32|29|218|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-33|29|238|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-34|29|244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-35|29|246|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-36|29|259|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-37|29|267|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-38|29|270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-39|29|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-40|29|271|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-41|29|291|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-42|29|294|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-43|29|296|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-44|29|313|Other deterministic changes|Whole body|n/a|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-45|29|332|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-46|29|358|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-47|29|367|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-48|29|377|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-49|29|440|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-29|n/a,TRD A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-29-50|29|491|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-1|30|34|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-2|30|50|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-3|30|50|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-4|30|56|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-5|30|71|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-6|30|77|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-7|30|77|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-8|30|84|Neoplasia systemic|Haematolymphatic system|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-9|30|91|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-10|30|98|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-11|30|101|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-12|30|105|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-13|30|112|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-14|30|115|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-15|30|119|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-16|30|140|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-17|30|144|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-18|30|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-19|30|159|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-20|30|159|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-21|30|160|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-22|30|162|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-23|30|168|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-24|30|178|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-25|30|183|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-26|30|183|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-27|30|189|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-28|30|190|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-29|30|193|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-30|30|194|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-31|30|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-32|30|197|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-33|30|202|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-34|30|204|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-35|30|207|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-36|30|207|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-37|30|207|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-38|30|207|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-39|30|208|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-40|30|210|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-41|30|224|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-42|30|228|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-43|30|232|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-44|30|232|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-45|30|232|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-46|30|235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-47|30|235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-48|30|236|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-49|30|237|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-50|30|238|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-51|30|238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-52|30|239|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-53|30|239|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-54|30|239|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-55|30|244|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-56|30|256|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-57|30|257|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-58|30|258|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-59|30|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-60|30|265|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-61|30|266|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-62|30|270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-63|30|274|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-64|30|287|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-65|30|291|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-66|30|293|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-67|30|294|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-68|30|294|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-69|30|298|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-70|30|300|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-71|30|301|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-72|30|301|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-73|30|301|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-74|30|309|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-75|30|309|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-76|30|313|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-77|30|316|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-78|30|316|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-79|30|319|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-80|30|320|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-81|30|320|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-82|30|328|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-83|30|328|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-84|30|330|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-85|30|336|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-86|30|346|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-87|30|350|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-88|30|357|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-89|30|369|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-90|30|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-91|30|372|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-92|30|389|Other deterministic changes|Whole body|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-93|30|389|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-94|30|396|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-95|30|420|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-30|n/a,TRD A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|96 (96 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-30-96|30|448|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-1|31|54|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-2|31|54|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-3|31|54|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-4|31|55|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-5|31|56|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-6|31|69|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-7|31|71|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-8|31|76|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-9|31|76|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-10|31|78|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-11|31|78|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-12|31|83|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-13|31|83|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-14|31|84|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-15|31|84|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-16|31|91|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-17|31|91|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-18|31|95|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-19|31|113|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-20|31|117|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-21|31|119|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.-lymphatic leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-22|31|120|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-23|31|124|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-24|31|125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-25|31|133|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-26|31|134|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-27|31|140|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-28|31|143|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-29|31|150|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-30|31|151|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-31|31|155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-32|31|155|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-33|31|155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-34|31|160|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-35|31|161|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-36|31|176|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-37|31|176|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-38|31|178|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-39|31|179|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-40|31|179|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-41|31|181|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-42|31|186|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-43|31|186|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-44|31|186|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-45|31|190|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-46|31|193|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-47|31|194|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-48|31|194|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-49|31|195|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-50|31|197|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-51|31|203|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-52|31|207|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-53|31|208|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-54|31|208|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-55|31|209|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-56|31|215|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.-lymphatic leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-57|31|222|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-58|31|225|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-59|31|225|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-60|31|225|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-61|31|229|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-62|31|231|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-63|31|231|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-64|31|236|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-65|31|237|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-66|31|239|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-67|31|239|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-68|31|252|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-69|31|256|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-70|31|259|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-71|31|264|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-72|31|267|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-73|31|274|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-74|31|277|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-75|31|279|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-76|31|291|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-77|31|291|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-78|31|293|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-79|31|298|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-80|31|301|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-81|31|307|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-82|31|308|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-83|31|311|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-84|31|319|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-85|31|319|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-86|31|320|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-87|31|320|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-88|31|321|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-89|31|322|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-90|31|325|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-91|31|326|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-92|31|327|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-93|31|327|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-94|31|334|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-95|31|340|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-96|31|341|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-97|31|351|Other deterministic changes|Whole body|n/a|
5-5-31|n/a,TRD A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, NMRI|Female|Aged|full pathology|5-5-31-98|31|435|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-1|32|38|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-2|32|136|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-3|32|447|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-4|32|522|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-5|32|524|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-6|32|551|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-7|32|573|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-8|32|613|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-9|32|679|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-10|32|691|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-11|32|698|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-12|32|734|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-13|32|736|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-14|32|763|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-15|32|764|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-16|32|768|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-17|32|802|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-18|32|804|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-19|32|834|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-20|32|838|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-21|32|839|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-22|32|853|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-23|32|854|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-24|32|858|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-25|32|875|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-26|32|881|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-27|32|890|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-28|32|900|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-29|32|904|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-30|32|911|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-31|32|921|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-32|32|949|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-33|32|949|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-34|32|957|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-35|32|966|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-36|32|972|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-37|32|979|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-38|32|979|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-39|32|991|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-40|32|998|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-41|32|1000|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-42|32|1002|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001459 - bone|,MPATH: 218 - neoplasm|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-43|32|1008|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-44|32|1013|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-45|32|1020|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-46|32|1021|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-47|32|1030|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-48|32|1033|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-49|32|1040|Other deterministic changes|Whole body|n/a|
5-5-32|n/a,TRC J|1|107|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-32-50|32|1068|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-1|33|272|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-2|33|283|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-3|33|318|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-4|33|358|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-5|33|524|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-6|33|565|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-7|33|571|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-8|33|572|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-9|33|635|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-10|33|636|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-11|33|649|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-12|33|701|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-13|33|736|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-14|33|739|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-15|33|742|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-16|33|760|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-17|33|761|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-18|33|762|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-19|33|774|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-20|33|788|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-21|33|790|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-22|33|811|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-23|33|811|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-24|33|826|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-25|33|831|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-26|33|832|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-27|33|832|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-28|33|833|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-29|33|833|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-30|33|837|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-31|33|839|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-32|33|847|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-33|33|855|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-34|33|874|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-35|33|895|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-36|33|901|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-37|33|904|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-38|33|909|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-39|33|914|Other deterministic changes|Whole body|n/a|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-40|33|963|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-41|33|978|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-42|33|1005|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-33|n/a,TRC J1|1|107|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|43 (43 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-33-43|33|1014|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-1|34|214|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-2|34|237|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-3|34|250|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-4|34|274|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-5|34|281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-6|34|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-7|34|305|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-8|34|326|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-9|34|328|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-10|34|350|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-11|34|362|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-12|34|364|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-13|34|378|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-14|34|382|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-15|34|391|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-16|34|392|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-17|34|397|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-18|34|398|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-19|34|399|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-20|34|399|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-21|34|400|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-22|34|406|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-23|34|406|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-24|34|414|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-25|34|420|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-26|34|428|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-27|34|433|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-28|34|434|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-29|34|434|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-30|34|453|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-31|34|461|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-32|34|467|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-33|34|477|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-34|34|481|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-35|34|481|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-36|34|496|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-37|34|501|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-38|34|505|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-39|34|505|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-40|34|535|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-41|34|547|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-42|34|552|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-43|34|552|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001487 - mandible|,MPATH: 572 - ossifying fibroma|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-44|34|568|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-45|34|606|Other deterministic changes|Whole body|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-46|34|609|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-47|34|670|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-48|34|671|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-49|34|704|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-34|n/a,TRC J5|1|107|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Young Adult|full pathology|5-5-34-50|34|964|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-1|35|19|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-2|35|60|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-3|35|117|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-4|35|125|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-5|35|154|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-6|35|224|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|,MPATH: 551 - sarcoma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-7|35|229|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-8|35|239|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-9|35|256|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-10|35|274|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-11|35|298|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-12|35|316|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-13|35|320|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-14|35|322|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-15|35|326|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-16|35|326|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-17|35|336|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-18|35|342|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-19|35|358|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-20|35|378|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-21|35|378|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-22|35|393|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-23|35|398|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-24|35|403|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-25|35|406|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-26|35|407|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-27|35|410|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-28|35|431|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-29|35|431|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-30|35|434|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-31|35|435|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-32|35|439|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-33|35|446|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-34|35|446|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-35|35|463|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-36|35|501|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-37|35|503|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-38|35|514|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-39|35|522|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-40|35|536|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-41|35|536|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-42|35|539|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-43|35|546|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-44|35|546|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-45|35|552|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001459 - bone,MA: 0001459 - bone|,MPATH: 393 - osteoblastoma,MPATH: 395 - osteofibroma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-46|35|559|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-47|35|560|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-48|35|592|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|,MPATH: 551 - sarcoma|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-49|35|593|Other deterministic changes|Whole body|n/a|
5-5-35|n/a,TRC A|1|550|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-35-50|35|655|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-1|36|24|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-2|36|27|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-3|36|83|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-4|36|113|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-5|36|131|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-6|36|134|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-7|36|159|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-8|36|159|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-9|36|162|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-10|36|169|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-11|36|189|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-12|36|190|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-13|36|190|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-14|36|201|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-15|36|201|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-16|36|225|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-17|36|225|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-18|36|232|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-19|36|243|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-20|36|248|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-21|36|249|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-22|36|249|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-23|36|255|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-24|36|255|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-25|36|259|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-26|36|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-27|36|290|Neoplasia systemic|Haematolymphatic system|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-28|36|291|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-29|36|294|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-30|36|294|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-31|36|296|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-32|36|305|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-33|36|309|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-34|36|322|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-35|36|328|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-36|36|337|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-37|36|340|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-38|36|341|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-39|36|342|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-40|36|347|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-41|36|351|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-42|36|354|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-43|36|357|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-44|36|358|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-45|36|362|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-46|36|364|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-47|36|365|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-48|36|379|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-49|36|383|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-50|36|383|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-51|36|384|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-52|36|386|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-53|36|386|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-54|36|386|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-55|36|386|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-56|36|392|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-57|36|398|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-58|36|400|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-59|36|405|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-60|36|407|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-61|36|410|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-62|36|410|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-63|36|414|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-64|36|417|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-65|36|420|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-66|36|421|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-67|36|424|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-68|36|424|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001459 - bone,MA: 0001459 - bone|,MPATH: 393 - osteoblastoma,MPATH: 395 - osteofibroma|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-69|36|428|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-70|36|428|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-71|36|431|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-72|36|434|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-73|36|435|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-74|36|440|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-75|36|448|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-76|36|449|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-77|36|452|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-78|36|453|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-79|36|454|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-80|36|456|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-81|36|474|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-82|36|479|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-83|36|496|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-84|36|497|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-85|36|502|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-86|36|515|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-87|36|516|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-88|36|522|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-89|36|524|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-90|36|525|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-91|36|530|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-92|36|539|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-93|36|539|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-94|36|545|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-95|36|546|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-96|36|566|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-97|36|592|Other deterministic changes|Whole body|n/a|
5-5-36|n/a,TRC A1|1|550|Th-227 citrate|37|becquerels per g animal|Injection, intraperitoneal|single injection|98 (98 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-36-98|36|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-1|37|64|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-2|37|88|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-3|37|103|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-4|37|104|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-5|37|117|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-6|37|119|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-7|37|124|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-8|37|134|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-9|37|144|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-10|37|153|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-11|37|176|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-12|37|179|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-13|37|186|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-14|37|190|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-15|37|203|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-16|37|211|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-17|37|241|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-18|37|241|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-19|37|243|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-20|37|245|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-21|37|253|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-22|37|256|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-23|37|257|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-24|37|265|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-25|37|270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-26|37|274|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-27|37|277|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-28|37|278|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-29|37|279|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-30|37|280|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-31|37|283|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-32|37|291|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-33|37|296|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-34|37|298|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-35|37|298|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-36|37|298|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-37|37|298|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-38|37|299|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-39|37|300|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-40|37|300|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-41|37|305|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-42|37|305|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-43|37|305|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-44|37|306|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-45|37|308|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001487 - mandible|,MPATH: 572 - ossifying fibroma|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-46|37|308|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-47|37|312|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-48|37|313|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-49|37|318|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-50|37|319|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-51|37|319|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-52|37|320|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-53|37|320|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-54|37|320|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-55|37|321|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-56|37|321|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-57|37|323|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-58|37|326|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-59|37|328|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-60|37|329|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-61|37|329|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-62|37|329|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-63|37|330|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-64|37|330|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-65|37|330|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001487 - mandible|,MPATH: 572 - ossifying fibroma|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-66|37|333|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-67|37|335|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-68|37|335|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001487 - mandible|,MPATH: 572 - ossifying fibroma|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-69|37|335|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 507 - mast cell sarcoma|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-70|37|335|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-71|37|336|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-72|37|336|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-73|37|336|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-74|37|336|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-75|37|336|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-76|37|336|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-77|37|337|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-78|37|337|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-79|37|337|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001487 - mandible|,MPATH: 572 - ossifying fibroma|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-80|37|337|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-81|37|340|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-82|37|340|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-83|37|340|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-84|37|340|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-85|37|341|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-86|37|341|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-87|37|342|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-88|37|344|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-89|37|344|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-90|37|353|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-91|37|363|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-92|37|364|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-93|37|374|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-94|37|392|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-95|37|393|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-96|37|416|Other deterministic changes|Whole body|n/a|
5-5-37|n/a,TRC A5|1|550|Th-227 citrate|185|becquerels per g animal|Injection, intraperitoneal|single injection|97 (97 in ERA)|Mouse|Mouse, CBA|Female|Aged|full pathology|5-5-37-97|37|423|Other deterministic changes|Whole body|n/a|
